Harmony Gold Mining Company Limited (HMY) is rated "Hold". The stock represents a gold mining company with strong financials, ...

MDNA11 continues to show best-in-class potential in the ABILITY-1 study with an objective response rate (ORR) of 30% in the monotherapy dose expansion cohort among patients with cancer progression ...

Medicenna Therapeutics (MDNA) presented updated clinical results from the ongoing monotherapy dose expansion and combination dose escalation portions of the Phase 1/2 ABILITY-1 study evaluating MDNA11 ...

Can legislators really brag about a conservative-led economy when there are still so many unmet needs in our state?

The superintendent presented her capital improvement plan for fiscal years 2026-2035 to the school board on Tuesday.

Corbus Pharmaceuticals still shows promise, with CRB-701 and CRB-601 advancing in clinical trials. Read why CRBP stock is ...

Besides helping practice literacy basics — letters, words, sentence structure — and helping ... and children from lower-income households “enter kindergarten with substantially lower reading skills ...

Advancing investigation of [212Pb]VMT01 as a monotherapy and in combination with the anti-PD-1 antibody, nivolumab, in patients with previously ...

MDNA11 continues to show best-in-class potential in the ABILITY-1 study with an objective response rate (ORR) of 30% in the monotherapy dose expansion cohort among patients with cancer progression aft ...

The Children’s Room of the Bennington Free Library was alive with 3- and 4-year-olds during a visit from the North Bennington ...

Tim Caulfield, health law professor at the University of Alberta, joined CTV Morning Live’s Kent Morrison to separate real ...